CXCL10 and myeloid sarcoma: Some studies demonstrated that CXCL10 expression is highly upregulated by IL1β and IFNγ, in hypertrophic astrocytes surrounding active MS lesions, and CXCL10 finally interferes with myelin formation by acting on CXCR3 receptors on oligodendrocytes 92, 104-106.